Other News

Exo® Launches FDA-Cleared AI on Exo Iris™ to Address Heart Failure

April 23, 2024 08:30 AM Eastern Daylight Time SANTA CLARA, Calif.–(BUSINESS WIRE)–Exo® (pronounced “echo”), a medical imaging software and devices company, today announced its FDA-cleared cardiac and lung artificial intelligence (AI) applications are now available on Exo Iris™, Exo’s high-performance handheld ultrasound device. “Exo’s AI is simple to use, reproducible and objective, and will […]

Cedar Gate’s Heart Disease & Heart Failure Predictive AI Models Could Save $1.4 Billion with Early Intervention

April 23, 2024 09:00 AM Eastern Daylight Time GREENWICH, Conn.–(BUSINESS WIRE)–Cedar Gate Technologies (Cedar Gate) announced that an analysis of their national Healthcare Benchmark Database, encompassing nearly 13 million member lives, revealed a potential savings opportunity of approximately $1.4 billion. Machine learning models within Cedar Gate’s platform can identify, with a […]

Bolt Medical Announces Completion of Enrollment of RESTORE ATK Pivotal Trial for the Unique Bolt Intravascular Lithotripsy System

Bolt Medical completes the enrollment of RESTORE ATK pivotal trial for the treatment of peripheral arterial disease with its unique intravascular lithotripsy system. CARLSBAD, Calif., April 22, 2024 /PRNewswire-PRWeb/ — Bolt Medical, Inc., a clinical stage medical device company is…

SS Innovations International Announces Q1 2024 Company Updates

Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system FORT LAUDERDALE, Fla., April 22, 2024 (GLOBE NEWSWIRE) — SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global […]

HeartCore Expands Partnership with Heart-Tech Health

NEW YORK and TOKYO, April 22, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, announced its Artificial Intelligence (AI) Software Development Division (“AI Division”) has engaged with Heart-Tech Health to implement AI capabilities into its Med-Tech […]

Innovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for vessels of the peripheral arterial and venous systems

PLEASANTON, Calif., April 22, 2024 /PRNewswire/ — Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food and Drug Administration. This announcement introduces a new and exciting player in the peripheral thrombectomy market. The ICE…

Recor Medical Announces First Cases of Paradise Ultrasound Renal Denervation Therapy in the United Arab Emirates

Palo Alto, CA, April 18, 2024 (GLOBE NEWSWIRE) — Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), announce the first commercial uses of Recor’s Paradise™ Ultrasound Renal Denervation (uRDN) system for the treatment of hypertension in the United Arab Emirates (UAE). Three cases were […]